G01N 2333/9645
Factor ix
Official title: Factor IX (3.4.21.22)
G01N2333/9645 (Factor ix) appears on 24 US grants and 21 published applications in this corpus.
Search patents in G01N- Granted patents
- 24
- Published applications
- 21
- Assignees
- 26
- Inventors
- 58
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 3 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 2 | 4 |
| 2019 | 0 | 1 |
| 2020 | 3 | 2 |
| 2021 | 3 | 3 |
| 2022 | 1 | 3 |
| 2023 | 1 | 0 |
| 2024 | 1 | 2 |
| 2025 | 2 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for detecting bi-specific antibody complex9 Dec 2025US 12,493,033 B2Chugai Seiyaku Kabushiki Kaisha
- Factor IX encoding nucleotides28 Jan 2025US 12,209,262 B2UCL Business PLC
- Anti-factor IX padua antibodies4 Jun 2024US 11,999,798 B2Takeda Pharmaceutical Company Limited
- Assays to monitor bleeding disorders5 Sep 2023US 11,747,351 B2Bioverativ Therapeutics Inc.
- Blood factor monitoring assay and uses thereof28 Jun 2022US 11,372,008 B2Bioverativ Therapeutics Inc.
- Methods and devices for detection of coagulation impairment3 Sep 2026US 2026/0259231 A1Coagulo Medical Technologies, Inc.
- Recombinant factor ix proteins, methods of making, and methods of using the same in non-hemophilic subjects17 Apr 2025US 2025/0122493 A1The University of North Carolina at Chapel Hill
- Novel antithrombotic antibody5 Sep 2024US 2024/0294668 A1Shanghai Synvida Biotechnology Co. Ltd.
- Blood coagulation reaction analysis method25 Jan 2024US 2024/0027476 A1Sekisui Medical Co., Ltd.
- Blood factor monitoring assay and uses thereof29 Dec 2022US 2022/0412996 A1Bioverativ Therapeutics Inc.
Most cited
By later US patents
- Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation33US 5,839,443 AThe Trustees of Columbia University in the City of New York · 1998
- Concentrates of coagulation factors II, VII, IX and X, method of their preparation and use24US 5,118,614 ATessek sdruzeni Praha · 1992
- Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation21US 6,391,300 B1The Trustees of Columbia University in the City of New York · 2002
- Reagent used for determining factor VIII activity14US 5,506,112 AImmuno Aktiengesellschaft · 1996
- Method for determining the functional activity of free protein S or protein C in a plasma sample13US 5,439,802 AChromogenix AB · 1995